Trial NCT02613910

View at ClinicalTrials.gov 
Org. Study IDs: 117059

Last trial update was posted on 2017-06-14

MeSH Interventions

Acetaminophen Cetirizine Histamine Antagonists Histamine H1 Antagonists Ofatumumab Prednisolone Prednisone

MeSH Conditions

Pemphigus

Other Conditions


Stopping Reasons

Novartis has acquired the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID